Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-000624-20Phase 3Completed
Phase 3, randomised trial of iloprost in osteonecrosis of the hip (2 arms), sponsored by Leipzig University. Primary endpoint: Harris Hip Score at 12 months. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-000624-20.